Jesper van Breeschoten
7PUBLICATIONS
24CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|Apr 27, 2023
Real-world Outcomes of Ipilimumab Plus Nivolumab Combination Therapy in a Nation-wide Cohort of Advanced Melanoma Patients in the Netherlands.Michiel C T van Zeijl, Jesper van Breeschoten, Liesbeth C de Wreede
|Aug 09, 2022
End-of-Life Use of Systemic Therapy in Patients With Advanced Melanoma: A Nationwide Cohort Study.Jesper van Breeschoten, Rawa K Ismail, Michel W J M Wouters
|Jun 23, 2022
Medication Use and Clinical Outcomes by the Dutch Institute for Clinical Auditing Medicines Program: Quantitative Analysis.Rawa Kamaran Ismail, Jesper van Breeschoten, Silvia van der Flier
|Oct 23, 2021
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.Jesper van Breeschoten, Alfonsus J M van den Eertwegh, Liesbeth C de Wreede
|Oct 04, 2021
The unfavorable effects of COVID-19 on Dutch advanced melanoma care.Olivier J van Not, Jesper van Breeschoten, Alfonsus J M van den Eertwegh
Pageof 2
Frequent Collaborators
4 joint publications
Michel Wouters
3 joint publications
Rawa Kamaran Ismail
2 joint publications
Karijn P M Suijkerbuijk
2 joint publications
John B Haanen
1 joint publications
Monique K van der Kooij
1 joint publications
Geke A P Hospers
1 joint publications
Michiel C T van Zeijl
1 joint publications
Olaf M Dekkers
1 joint publications
Olivier J van Not
1 joint publications
Ellen Kapiteijn
